Aqmen Medtech Profile
Key Indicators
- Authorised Capital ₹ 5.20 Cr
as on 18-07-2024
- Paid Up Capital ₹ 4.56 Cr
as on 18-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 18-07-2024
- Revenue 81.64%
(FY 2023)
- Profit 101.73%
(FY 2023)
- Ebitda 99.87%
(FY 2023)
- Net Worth 780.02%
(FY 2023)
- Total Assets 92.07%
(FY 2023)
About Aqmen Medtech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.20 Cr and a paid-up capital of Rs 4.56 Cr.
The company currently has active open charges totaling ₹1.00 Cr.
Subramanian Shivaraman, Pedda Reddy, Debasis Dutta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85300KA2018PTC147151
- Company No.
227051
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2018
- Date of AGM
11 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aqmen Medtech Private Limited offer?
Aqmen Medtech Private Limited offers a wide range of products and services, including Bandages & Dressing Disposables, Hospital Dressings, Scalpels, Needles & Scissors, Non Absorbable Sutures, Absorbable Sutures.
Who are the key members and board of directors at Aqmen Medtech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Singh  | Director | 05-Apr-2023 | Current |
| Tejas Subramanian | Director | 28-Mar-2023 | Current |
| Pedda Reddy | Director | 12-Apr-2021 | Current |
| Debasis Dutta | Director | 12-Apr-2021 | Current |
| Subramanian Shivaraman | Additional Director | 25-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Aqmen Medtech.
Aqmen Medtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.64% increase. The company also saw a substantial improvement in profitability, with a 101.73% increase in profit. The company's net worth Soared by an impressive increase of 780.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aqmen Medtech?
In 2023, Aqmen Medtech had a promoter holding of 16.18% and a public holding of 83.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fibroheal Woundcare Private LimitedActive 7 years 8 monthsSubramanian Shivaraman is a mutual person
Just Games LlpActive 8 years 3 monthsSubramanian Shivaraman and Tejas Subramanian are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 May 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Aqmen Medtech?
Aqmen Medtech has a workforce of 143 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aqmen Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aqmen Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
